The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Trends in Breast Cancer by Race and Ethnicity
Open accessAbstract
In this article, the American Cancer Society (ACS) describes trends in incidence, mortality, and survival rates of female breast cancer in the United States by race and ethnicity. It also provides estimates of new cases and deaths and shows trends in screening mammography. The incidence and survival data derive from the National Cancer Institute's Surveillance, Epidemiology, and End Results program; mortality data are from the National Center for Health Statistics. Approximately 211,300 new cases of invasive breast cancer, 55,700 in situ cases, and 39,800 deaths are expected to occur among women in the United States in 2003. Breast cancer incidence rates have increased among women of all races combined and white women since the early 1980s. The increasing rate in white women predominantly involves small (< or = 2 cm) and localized-stage tumors, although a small increase in the incidence of regional-stage tumors and those larger than five cm occurred since the early 1990s. The incidence rate among African American women stabilized during the 1990s for all breast cancers and for localized tumors. African American women are more likely than white women to be diagnosed with large tumors and distant-stage disease. Other racial and ethnic groups have lower incidence rates than do either white or African American women. However, the proportion of disease diagnosed at advanced stage and with larger tumor size in all minorities is greater than in white persons. Death rates decreased by 2.5% per year among white women since 1990 and by 1% per year among African American women since 1991. The disparity in mortality rates between white and African American women increased progressively between 1980 and 2000, so that by 2000 the age-standardized death rate was 32% higher in African Americans. Clinicians should be aware that 63% and 29% of breast cancers are diagnosed at local- and regional-stage disease, for which the five-year relative survival rates are 97% and 79%, respectively. This information, coupled with decreasing mortality rates and improvements in treatment, may motivate women to have regular mammographic and clinical breast examinations. Continued efforts are needed to increase the availability of high-quality mammography and treatment to all segments of the population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
Permutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.1.5 · Cited by 3,275
Self-citationStewart, B. W., & Kleihues, P. (2003) · Cited by 2,386
Focan, C., Steinberg, S. M., Blichert-Toft, M., Forbes, J., Collins, R. D., Anderson, S., Margreiter, R., Harwood, C. S., Andersen, K., Beighton, G., et al. (1998) · PubMed · Cited by 2,146
Polychemotherapy for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(98)03301-7 · Cited by 2,042
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M., Lane, D., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · JAMA · doi:10.1001/jama.289.24.3243 · Cited by 1,872
Kim, H. (2001) · Statistics in Medicine · doi:10.1002/sim.811 · Cited by 873
American Cancer Society Guidelines for Breast Cancer Screening: Update 2003
Smith, R. A., Saslow, D., Andrews Sawyer, K., Burke, W., Costanza, M. E., Evans, W. P., Foster, R. S., Hendrick, E., Eyre, H. J., & Sener, S. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.3.141 · Cited by 770
Self-citationIncidence of and Treatment for Ductal Carcinoma In Situ of the Breast
Ernster, V. L. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530360023033 · Cited by 626
Clegg, L. X., Li, F. P., Hankey, B. F., Chu, K., & Edwards, B. K. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.17.1985 · Cited by 535
Survival of Blacks and Whites After a Cancer Diagnosis
Bach, P. B. (2002) · JAMA · doi:10.1001/jama.287.16.2106 · Cited by 513
Geographic Variation in the Treatment of Localized Breast Cancer
Farrow, D. C., Hunt, W. C., & Samet, J. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261701 · Cited by 477
Recent Trends in U.S. Breast Cancer Incidence, Survival, and Mortality Rates
Chu, K. C., Tarone, R. E., Kessler, L. G., Ries, L. A. G., Hankey, B. F., Miller, B. A., & Edwards, B. K. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.21.1571 · Cited by 430
Factors Associated With Surgical and Radiation Therapy for Early Stage Breast Cancer in Older Women
Ballard-Barbash, R., Potosky, A. L., Harlan, L. C., Nayfield, S. G., & Kessler, L. G. (1996) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/88.11.716 · Cited by 374
Mandelblatt, J. S., Hadley, J., Kerner, J. F., Schulman, K. A., Gold, K., Dunmore-Griffith, J., Edge, S., Guadagnoli, E., Lynch, J. J., Meropol, N. J., et al. (2000) · Cancer · doi:10.1002/1097-0142(20000801)89:3<561::aid-cncr11>3.0.co;2-a · Cited by 277
Brett, K. M., & Madans, J. H. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009142 · Cited by 241
Changing trends: An overview of breast cancer incidence and mortality
Garfinkel, L., Boring, C. C., & Heath, C. W. (1994) · Cancer · doi:10.1002/cncr.2820741304 · Cited by 158
Wójcik, B. E., Spinks, M. K., & Optenberg, S. A. (1998) · Cancer · Cited by 154
Mariotto, A. B. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.21.1626 · Cited by 151
Caplan, L. S., May, D. S., & Richardson, L. C. (2000) · American Journal of Public Health · doi:10.2105/ajph.90.1.130 · Cited by 147
Racial differences in treatment and survival from early‐stage breast carcinoma
Joslyn, S. A. (2002) · Cancer · doi:10.1002/cncr.10827 · Cited by 129
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M. L. S., Lane, D. S., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000093674.44946.d6 · Cited by 119
Disaggregating the Effects of Race and Poverty on Breast Cancer Outcomes
Brawley, O. W. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.7.471 · Cited by 81
Chemoprevention of Breast Cancer: Recommendations and Rationale
U.S. Preventive Services Task Force* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00016 · Cited by 81
Implications of Birth Cohort Patterns in Interpreting Trends in Breast Cancer Rates
Tarone, R. E., & Chu, K. C. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.18.1402 · Cited by 74
Hamilton, B. E., Sutton, P. D., & Ventura, S. J. (2003) · PubMed · Cited by 67
Handbook of Women’s Sexual and Reproductive Health
(2002) · Springer eBooks · doi:10.1007/978-1-4615-0689-8 · Cited by 66
The "epidemic" of breast cancer in the U.S.--determining the factors.
King, S. E., & Schottenfeld, D. (1996) · PubMed · Cited by 23
Cited by
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
“The historically higher incidence rate among white women is thought to reflect a combination of factors that affect both diagnosis (more prevalent mammography) and underlying disease occurrence (such as later age at first birth and greater use of menopausal hormone therapy).(63) However, a recent study reported that b…”
BackgroundSelf-citationJemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Self-citationSiegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Self-citationSiegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Self-citationSiegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Self-citation
Metadata
- Authors
- Ghafoor, A., Jemal, A., Ward, E., Cokkinides, V., Smith, R., & Thun, M.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2003-11-01
- Volume
- 53
- Issue
- 6
- Pages
- 342-355
- ISSN
- 0007-9235 (ISSN-L)
- OpenAlex
- W2118651985
- Cited by
- 451
- References
- 30
- FWCI
- 11.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.